# Commission Directive 2005/28/EC of 8 April 2005 laying down principles and detailed guidelines for good clinical practice as regards investigational medicinal products for human use, as well as the requirements for authorisation of the manufacturing or importation of such products (Text with EEA relevance), Article 26

Extent: E+W+S+N.I.

Member States shall establish the relevant procedures for verification of good clinical practice compliance.
The procedures shall include the modalities for examining both the study management procedures and the conditions under which clinical trials are planned, performed, monitored and recorded, as well as follow-up measures.

---
Source: https://www.legislation.gov.uk/eudr/2005/28/article/26 (the official version)
Page: https://openlegislation.uk/eu-directive-2005-28/article-26
Contains public sector information licensed under the Open Government Licence v3.0. Source: legislation.gov.uk, The National Archives.